Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
0.2666
-0.0284 (-9.63%)
At close: May 14, 2025, 4:00 PM
0.2799
+0.0133 (4.99%)
After-hours: May 14, 2025, 7:30 PM EDT
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $16.57 million as of May 14, 2025. Its market cap has decreased by -79.63% in one year.
Market Cap
16.57M
Enterprise Value
-20.42M
1-Year Change
-79.63%
Ranking
Category
Stock Price
$0.27
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $16.57M, a decrease of -98.27%. That is a compound annual growth rate of -54.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 18.33M | -47.66% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | 1.16B | 21.70% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 673.96B |
| Johnson & Johnson | 360.45B |
| AbbVie | 329.78B |
| UnitedHealth Group | 298.88B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 227.94B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |